Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 12, 2018

Study Completion Date

September 12, 2018

Conditions
Barrett's EsophagusObesity
Interventions
DRUG

Omega-3 polyunsaturated fatty acids

3 capsules a day of Omega 3 polyunsaturated fatty acids taken orally for six months; 2 capsules with breakfast and 1 capsule with their evening meal. Active drug will consist of 1200 mg of a ω3 FFA preparation containing 675 mg EPA and 300 mg DHA.

DRUG

Placebo

3 capsules a day of placebo (1200 mg of ethyl oleate 3 capsules a day) taken orally for six months; 2 capsules with breakfast and 1 capsule with their evening meal.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER